This measure assesses the appropriate use of echocardiograms in patients with CHF. It evaluates the percentage of patients who receive echocardiograms without a clinical change or cardiac procedure within 24 months of the date of service (DOS), indicating potential overuse of this diagnostic test.
Category: Quality Measures
SGLT2 Inhibitors for Patients with Chronic Kidney Disease (CKD) with or without type 2 diabetes mellitus
This measure evaluates the percentage of patients aged 18 years and older with chronic kidney disease (CKD) stages 2 and 3 who are prescribed an SGLT2 inhibitor during the measurement period. The goal is to increase the use of SGLT2 inhibitors, which have been shown to slow the progression of CKD and reduce cardiovascular events in this population.
Noninvasive Ischemic Imaging Stewardship in Chronic Coronary Disease: Avoiding Testing without Clinical Indication
This measure assesses the appropriate use of noninvasive ischemic imaging in patients with chronic coronary disease in accordance with the 2023 ACC/AHA guidelines on the management of chronic coronary disease. It evaluates the percentage of patients who received imaging without a clinical change or pre-operative indication, signaling potential overuse of cardiac imaging.
Avoidance of Cerebral Hyperthermia for Procedures Involving Cardiopulmonary Bypass
Percentage of patients, aged 18 years and older, undergoing a procedure using cardiopulmonary bypass who did not have a documented intraoperative pulmonary artery, oropharyngeal, or nasopharyngeal temperature greater than or equal to 37.0 degrees Celsius during the period of cardiopulmonary bypass
Ambulatory Glucose Management
Percentage of diabetic patients, aged 18 years and older, who receive an office-based or ambulatory surgery whose blood glucose level is appropriately managed throughout the perioperative period.
The measure consists of four performance rates:
a. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery whose blood glucose level is tested prior to the start of anesthesia
b. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level greater than or equal to 180 mg/dL (10.0 mmol/L) who received insulin prior to anesthesia end time
c. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who received insulin perioperatively and who received a follow-up blood glucose level check following the administration of insulin and prior to discharge
d. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services for office-based or ambulatory surgery who experienced a blood glucose level greater than or equal to 180 mg/dL (10.0 mmol/L) who received education on managing their glucose in the postoperative period prior to discharge
Neuromuscular Blockade and Quantitative Train-of-Four
The percentage of patients, aged 1 and above, who undergo a surgical, therapeutic, or diagnostic procedure that involves using a non-depolarizing neuromuscular blockade medication who have a documented quantitative train-of-four ratio of greater than or equal to 0.9 before tracheal extubation in the operating room, post-anesthesia care unit, non-operating room anesthetizing location, or earliest extubation.
Physical Health Outcomes in Total Hip and Knee Arthroplasty
Percentage of patients with patient-reported meaningful improvement in anatomic specific HOOS/KOOS JR after elective total hip and knee arthroplasty.
Improvement in Pain Assessment Following Spine Fusion Procedures
Percentage of patients with patient-reported meaningful improvement in pain following lumbar or cervical spine procedures
Coronary Artery Bypass Graft (CABG): Prolonged Intubation – Inverse Measure
Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation greater than 24 hours
Patient-Reported Experience with Anesthesia
Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care and who reported a positive experience.
This measure will consist of two performance rates:
AQI48a: Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care
AQI48b: Percentage of patients, aged 18 and older, who completed a survey on their patient experience and satisfaction with anesthesia care who report a positive experience with anesthesia care within 60 days of receipt of the survey.
NOTE: The measure requires that a valid survey, as defined in the numerator of AQI48a, be sent to patients between discharge from the facility and within 30 days of facility discharge. To report AQI48b, a minimum number of 20 surveys with the mandatory question completed must be reported. ** In order to be scored on this measure, clinicians must report BOTH AQI48a AND AQI48b.